IDiyas

For the Inventor, By the Inventor

Nishinomiya, Japan

Michihiro Yamamoto

USPTO Granted Patents = 28

Average Co-Inventor Count = 4.6

ph-index = 7

Forward Citations = 131(Granted Patents)


Location History:

  • Takarazuka, JA (1977)
  • Nishinomiya, JA (1976 - 1978)
  • Toyonaka, JA (1976 - 1978)
  • Toyonaka, JP (1978 - 1980)
  • Nishinomiya, JP (1979 - 1999)

Company Filing History:

goldMedal23 out of 6,892 
 
Sumitomo Chemical Company, Limited
 patents
silverMedal5 out of 174 
 
Sumitomo Pharmaceuticals Company Limited
 patents

Years Active: 1976-1999

Loading Chart...
28 patents (USPTO):Explore Patents
1. 5962438 - Estrogen derivative having carriers to bone (1999-10-05),
2. 5180731 - Aminoazole derivatives and their production and use (1993-01-19),
3. 5066666 - Aminoazole derivatives and their production and use (1991-11-19),
4. 4914112 - Aminoazole derivatives and their production and use (1990-04-03),
5. 4705786 - Novel oxadiazolyl-1,4-dihydropyridines useful as antihypertensive agents (1987-11-10),
6. 4680307 - Carbacyclin analogs (1987-07-14),
7. 4618617 - Novel 5-substituted 1,2,4,-oxadiazole derivatives and preparation thereof (1986-10-21),
8. 4537989 - Imino-bicyclo (3.3.0) octane derivatives (1985-08-27),
9. 4387223 - Process for preparing 2(1H)-quinazolinone derivatives (1983-06-07),
10. 4228167 - Diuretic and vasodilating tricyclic quinazolines (1980-10-14),
11. 4202974 - Process for preparing 3,4-dihydro-2(1H)-quinazolinone derivatives (1980-05-13),
12. 4202895 - 1-Polyhaloalkyl-2(1H)-quinazolinone derivatives (1980-05-13),
13. 4183932 - Fused quinazolinones and preparation thereof (1980-01-15),
14. 4179560 - Imidazo- and pyrimido[2,1-b]quinazolines and preparation thereof (1979-12-18),
15. 4146717 - Nitroquinazolinone compounds having antiviral properties (1979-03-27),

Title: The Innovations of Michihiro Yamamoto: A Pioneer in Pharmaceuticals

Introduction: Michihiro Yamamoto, based in Nishinomiya, Japan, is a prolific inventor with an impressive portfolio of 28 patents. His contributions primarily focus on pharmaceutical chemistry, showcasing a significant commitment to advancing medical science through innovative solutions.

Latest Patents: Among his latest inventions, Michihiro Yamamoto has developed an estrogen derivative with carriers to bone, as well as aminoazole derivatives along with their production and use. Furthermore, he has patented a compound of a specific formula, demonstrating his expertise in complex chemical formulations.

Career Highlights: Yamamoto's career spans several influential companies, including Sumitomo Chemical Company Limited and Sumitomo Pharmaceuticals Company Limited. His role in these organizations has allowed him to contribute significantly to the development of new therapeutic agents and chemical compounds that have the potential to enhance patient treatment options.

Collaborations: Throughout his career, Michihiro Yamamoto has collaborated with notable colleagues, including Hisao Yamamoto and Shigeho Inaba. These partnerships have facilitated the exchange of ideas and innovations, enriching the pharmaceutical landscape.

Conclusion: Michihiro Yamamoto stands out as a key figure in the field of pharmaceuticals, with a remarkable track record of patents and collaborative efforts. His ongoing work continues to inspire future innovations within the industry, and his contributions are valued by peers and institutions alike.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…